Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases
- 22 September 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 137 (5), 865-873
- https://doi.org/10.1007/s00432-010-0948-y
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Liver metastases from colorectal cancer: radioembolization with systemic therapyNature Reviews Clinical Oncology, 2009
- Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysisEuropean Radiology, 2008
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Expanding Criteria for Resectability of Colorectal Liver MetastasesThe Oncologist, 2008
- Reduction of Arteriohepatovenous Shunting by Temporary Balloon Occlusion in Patients Undergoing RadioembolizationJournal of Vascular and Interventional Radiology, 2007
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines CureJournal of Clinical Oncology, 2007
- Technical Complications and Durability of Hepatic Artery Infusion Pumps for Unresectable Colorectal Liver Metastases: An Institutional Experience of 544 Consecutive CasesJournal of the American College of Surgeons, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapyPhysics in Medicine & Biology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000